🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Levent Mutlu

Yale University

ORCID: 0009-0000-5861-9277

Also affiliated with Smilow Cancer Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancer”.

Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.028
N/A
0.879DataRank · unranked
31 citations

Cem Demirkiran, Tobias M.P. Hartwich, Stefania Bellone, Diego Manavella, Levent Mutlu +10 more

Antibody–Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors

Molecules(2023)10.3390/molecules28217389
N/A
0.434DataRank · unranked
17 citations

Michelle Greenman, Nicole Pebley, Levent Mutlu, Alessandro D. Santin, Blair McNamara

Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers

International Journal of Molecular Sciences(2023)10.3390/ijms24108873
N/A
0.406DataRank · unranked
14 citations

Blair McNamara, Levent Mutlu, Cem Demirkiran, Tobias M.P. Hartwich, Justin Harold +4 more

Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2

Clinical & Experimental Metastasis(2024)10.1007/s10585-024-10297-z
N/A
0.360DataRank · unranked
10 citations

Blair McNamara, Stefania Bellone, Diego Manavella, Cem Demirkiran, Michelle Greenman +16 more

Therapeutic role of uterine-derived stem cells in acute kidney injury

Stem Cell Research & Therapy(2022)10.1186/s13287-022-02789-0
N/A
0.292DataRank · unranked
6 citations

SiHyun Cho, Levent Mutlu, Hugh S. Taylor, Ramanaiah Mamillapalli

Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.03.009
N/A
0.241DataRank · unranked
4 citations

Justin Harold, Diego Manavella, Stefania Bellone, Levent Mutlu, Tobias M.P. Hartwich +24 more

Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.014
N/A
0DataRank · unranked
30 citations

Stefania Bellone, Diego Manavella, Levent Mutlu, Blair McNamara, Tobias M.P. Hartwich +17 more

Entering the golden age for antibody-drug conjugates in gynecologic cancer

Oncoscience(2024)10.18632/oncoscience.604
N/A
0DataRank · unranked
0 citations

Blair McNamara, Levent Mutlu, Alessandro D. Santin, Michelle Greenman

Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.05.005
N/A
0DataRank · unranked
25 citations

Paola Manara, Diego Manavella, Stefania Bellone, Tobias M.P. Hartwich, Justin Harold +17 more

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma

Cancers(2023)10.3390/cancers15164085
N/A
0DataRank · unranked
15 citations

Levent Mutlu, Michelle Greenman, Justin Harold, Alessandro D. Santin, Blair McNamara

In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0126
N/A
0DataRank · unranked
8 citations

Diego Manavella, Stefania Bellone, Blair McNamara, Justin Harold, Dennis Mauricio +17 more

Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2321898121
N/A
0DataRank · unranked
18 citations

Kyungjo Jeong, Mari K. Halle, Camilla Krakstad, Blair McNamara, Michelle Greenman +33 more

Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.04.010
N/A
0DataRank · unranked
9 citations

Michelle Greenman, Stefania Bellone, Blair McNamara, Tobias M.P. Hartwich, Diego Manavella +10 more